SPECTRAL AI, INC. Right-of-Use Asset Obtained in Exchange for Operating Lease Liability
SPECTRAL AI, INC. (MDAI) reported Right-of-Use Asset Obtained in Exchange for Operating Lease Liability of $1.77 million for the 12-month period ending 2024-12-31, per its 10-K filed 2026-03-25.
Financial Statements › Notes › Leases
us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability · last filed 2026-03-25
- SPECTRAL AI, INC. right-of-use asset obtained in exchange for operating lease liability for the quarter ending 2024-12-31 was $0.00.
- SPECTRAL AI, INC. right-of-use asset obtained in exchange for operating lease liability for the quarter ending 2024-09-30 was $0.00.
- SPECTRAL AI, INC. right-of-use asset obtained in exchange for operating lease liability for the quarter ending 2024-06-30 was $1.77M, a 266.67% increase year-over-year.
- SPECTRAL AI, INC. right-of-use asset obtained in exchange for operating lease liability for the quarter ending 2023-12-31 was $0.00, a 100.00% decline year-over-year.
- SPECTRAL AI, INC. right-of-use asset obtained in exchange for operating lease liability for fiscal 2024 was $1.77M, a 266.67% increase from fiscal 2023.
- SPECTRAL AI, INC. right-of-use asset obtained in exchange for operating lease liability for fiscal 2023 was $483.00K, a 69.14% decline from fiscal 2022.
- SPECTRAL AI, INC. right-of-use asset obtained in exchange for operating lease liability for fiscal 2022 was $1.56M.
| Period end | Right-of-Use Asset Obtained in Exchange for Operating Lease Liability 3 month | Right-of-Use Asset Obtained in Exchange for Operating Lease Liability 6 month | Right-of-Use Asset Obtained in Exchange for Operating Lease Liability 9 month | Right-of-Use Asset Obtained in Exchange for Operating Lease Liability 12 month |
|---|---|---|---|---|
| 2024-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-25 | $0.00 derived: sum of 2 quarters · filed 2026-03-25 | $1.77M derived: sum of 3 quarters · filed 2026-03-25 | $1.77M 10-K · filed 2026-03-25 |
| 2024-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-06 | $1.77M derived: sum of 2 quarters · filed 2024-11-06 | $1.77M 10-Q · filed 2024-11-06 | |
| 2024-06-30 | $1.77M 10-Q · filed 2024-08-12 | $1.77M 10-Q · filed 2024-08-12 | ||
| 2023-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-31 | $0.00 derived: sum of 2 quarters · filed 2025-03-31 | $483.00K derived: sum of 3 quarters · filed 2025-03-31 | $483.00K 10-K · filed 2025-03-31 |
| 2023-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-06 | $483.00K derived: sum of 2 quarters · filed 2024-11-06 | $483.00K 10-Q · filed 2024-11-06 | |
| 2023-06-30 | $483.00K 10-Q · filed 2024-08-12 | $483.00K 10-Q · filed 2024-08-12 | ||
| 2022-12-31 | $941.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-29 | $941.00K derived: sum of 2 quarters · filed 2024-03-29 | $956.00K derived: sum of 3 quarters · filed 2024-03-29 | $1.56M 10-K · filed 2024-03-29 |
| 2022-09-30 | $0.00 derived: 10-Q 9 month − 8-K 6 month · filed 2023-11-14 | $15.00K derived: sum of 2 quarters · filed 2023-11-14 | $624.00K 10-Q · filed 2023-11-14 | |
| 2022-06-30 | $15.00K 8-K · filed 2023-09-15 | $624.00K 8-K · filed 2023-09-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Xtant Medical Holdings, Inc. (XTNT) | United States | $0.053B | |
| Sensus Healthcare, Inc. (SRTS) | United States | $0.048B | -3.24 |
| TELA Bio, Inc. (TELA) | United States | $0.057B | -0.82 |
| NEPHROS INC (NEPH) | United States | $0.046B | 23.02 |
| SANUWAVE Health, Inc. (SNWV) | United States | $0.041B | 5.47 |
| DarioHealth Corp. (DRIO) | $0.066B | -1.39 | |
| CVRx, Inc. (CVRX) | United States | $0.067B | -2.62 |
| InspireMD, Inc. (NSPR) | $0.033B | ||
| PAVmed Inc. (PAVM) | United States | $0.031B | -3.00 |
| FRACTYL HEALTH, INC. (GUTS) | United States | $0.075B | -1.18 |